These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25096172)

  • 1. Media fill for validation of a good manufacturing practice-compliant cell production process.
    Serra M; Roseti L; Bassi A
    Methods Mol Biol; 2015; 1283():161-9. PubMed ID: 25096172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standard operating procedure for the good manufacturing practice-compliant production of human bone marrow mesenchymal stem cells.
    Roseti L; Serra M; Bassi A
    Methods Mol Biol; 2015; 1283():171-86. PubMed ID: 25092055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GMP-compliant human adipose tissue-derived mesenchymal stem cells for cellular therapy.
    Aghayan HR; Goodarzi P; Arjmand B
    Methods Mol Biol; 2015; 1283():93-107. PubMed ID: 25138723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of good manufacturing practice-grade human umbilical cord blood-derived mesenchymal stem cells for therapeutic use.
    Van Pham P; Phan NK
    Methods Mol Biol; 2015; 1283():73-85. PubMed ID: 25239529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications.
    Wuchter P; Bieback K; Schrezenmeier H; Bornhäuser M; Müller LP; Bönig H; Wagner W; Meisel R; Pavel P; Tonn T; Lang P; Müller I; Renner M; Malcherek G; Saffrich R; Buss EC; Horn P; Rojewski M; Schmitt A; Ho AD; Sanzenbacher R; Schmitt M
    Cytotherapy; 2015 Feb; 17(2):128-39. PubMed ID: 24856898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality Control Assays for Clinical-Grade Human Mesenchymal Stromal Cells: Methods for ATMP Release.
    Radrizzani M; Soncin S; Lo Cicero V; Andriolo G; Bolis S; Turchetto L
    Methods Mol Biol; 2016; 1416():313-37. PubMed ID: 27236681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation of GMP-compliant integration-free hiPSCs using modified mRNAs.
    Durruthy JD; Sebastiano V
    Methods Mol Biol; 2015; 1283():31-42. PubMed ID: 25304205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity.
    Castiglia S; Adamini A; Rustichelli D; Castello L; Mareschi K; Pinnetta G; Leone M; Mandese A; Ferrero I; Mesiano G; Fagioli F
    J Transl Med; 2018 Aug; 16(1):237. PubMed ID: 30157948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of routine evaluation of sterility of cellular therapy products with or without extensive manipulation: Best practices and clinical significance.
    Golay J; Pedrini O; Capelli C; Gotti E; Borleri G; Magri M; Vailati F; Passera M; Farina C; Rambaldi A; Introna M
    Cytotherapy; 2018 Feb; 20(2):262-270. PubMed ID: 29246649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using the quantum cell expansion system for the automated expansion of clinical-grade bone marrow-derived human mesenchymal stromal cells.
    Martin-Manso G; Hanley PJ
    Methods Mol Biol; 2015; 1283():53-63. PubMed ID: 25523809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of Good Manufacturing Practice (GMP) for Biomedical Cell Products.
    Tulina MA; Pyatigorskaya NV
    Bull Exp Biol Med; 2018 Mar; 164(4):579-582. PubMed ID: 29504094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A consensus introduction to serum replacements and serum-free media for cellular therapies.
    Karnieli O; Friedner OM; Allickson JG; Zhang N; Jung S; Fiorentini D; Abraham E; Eaker SS; Yong TK; Chan A; Griffiths S; Wehn AK; Oh S; Karnieli O
    Cytotherapy; 2017 Feb; 19(2):155-169. PubMed ID: 28017599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Media Fill Method for Solid Tissue Processing in Good Manufacturing Practice-Compliant Cell Production.
    Öztel ON; Aydoğdu N; Karaöz E
    Methods Mol Biol; 2021; 2286():67-71. PubMed ID: 33349901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cGMP-compliant transportation conditions for a prompt therapeutic use of marrow mesenchymal stromal/stem cells.
    Veronesi E; Burns JS; Murgia A; Candini O; Rasini V; Mastrolia I; Catani F; Paolucci P; Dominici M
    Methods Mol Biol; 2015; 1283():109-22. PubMed ID: 25108453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products.
    Khuu HM; Stock F; McGann M; Carter CS; Atkins JW; Murray PR; Read EJ
    Cytotherapy; 2004; 6(3):183-95. PubMed ID: 15203975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of mesenchymal stromal/stem cells according to good manufacturing practices: a review.
    Sensebé L; Gadelorge M; Fleury-Cappellesso S
    Stem Cell Res Ther; 2013 Jun; 4(3):66. PubMed ID: 23751270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Draft of Iranian National Guideline for Cell Therapy Manufacturing.
    Aghayan HR; Arjmand B; Ahmadbeigi N; Gheisari Y; Vasei M
    Arch Iran Med; 2017 Aug; 20(8):547-550. PubMed ID: 28846019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
    Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I
    Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The translation of cell-based therapies: clinical landscape and manufacturing challenges.
    Heathman TR; Nienow AW; McCall MJ; Coopman K; Kara B; Hewitt CJ
    Regen Med; 2015; 10(1):49-64. PubMed ID: 25562352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
    Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
    Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.